Abstract:ObjectiveTo investigate texture parameters of contrast-enhanced computed tomography (CT) images before and after transarterial chemoembolization (TACE) as a tool for assessing the therapeutic response and survival predication in hepatocellular carcinoma (HCC).Materials and methodsData of 77 HCC patients who underwent three-phase dynamic contrast-enhanced CT examination within 4 weeks before and 4–8 weeks after TACE were collected and efficacy evaluation was performed according to the modified Response Evaluation Criteria in Solid Tumors (mRECIST) standard. The remission group consisted of 31 patients (12 with complete remission+19 with partial remission), while the non-remission group consisted of 46 patients (27 with stable disease+19 with progressive disease). Full-volume manual delineation of the region of interest (ROI) and texture analysis of the ROI were performed on the CT images using FireVoxel software. Changes in the 48 texture parameters from three-phase CT images before and after TACE were calculated and compared between the two groups. The receiver operating characteristic (ROC) curve and the areas under the curve (AUC) were used to analyze the diagnostic performance of texture parameters. A multifactorial Cox model was used for predicting survival. The C-indices of texture parameter difference values with predictive value, texture features model, and texture features combined with mRECIST in predicting OS were compared with those of mRECIST.ResultsA total of 41 changes in texture parameters were statistically significant between the remission and non-remission groups. The receiver operating characteristic (ROC) curve showed that the AUC of changes in the 90th percentile in the arterial phase was the largest at 0.842. When the cut-off value was 70.50, the Youden index was the largest (0.621), and the sensitivity and specificity were 0.710 and 0.911, respectively. Three changes in texture parameters were independent factors associated with patient survival, with a hazard of 0.173, 2.068, and 1.940, respectively. The C-index of the OS predicted by the texture features model was not statistically different from that of the mRECIST (0.695 vs. 0.668, p=0.493). While the C-indices of skewness in the portal venous phase combined with mRECIST (0.729, p=0.015), skewness in the delayed phase combined with mRECIST (0.715, p=0.044), and skewness in both two phases combined with mRECIST (0.728, p=0.017) were statistically different.ConclusionChanges in the texture parameters of CT images before and after TACE treatment can be used to obtain relevant grayscale histogram parameters for evaluating the early efficacy of TACE in HCC treatment. And the texture analysis combined with mRECIST may be superior to the mRECIST alone in predicting survival in HCC after TACE treatment.

Analysis of Contrast-Enhanced CT Textures to Predict Survival of Patients with Primary Esophageal Cancer Treated with Definitive Chemotherapy and Radiation Therapy.

Textural Features Based Enhanced Contrast CT Images Predicts Prognosis to Concurrent Chemoradiotherapy in Stage III Esophageal Squamous Cell Cancer

Primary Esophageal Cancer: Heterogeneity as Potential Prognostic Biomarker in Patients Treated with Definitive Chemotherapy and Radiation Therapy

Texture analysis of CT imaging for assessment of esophageal squamous cancer aggressiveness.

Texture analysis based on CT for predicting the differentiation of esophageal squamous cancer: An observational study

SU‐E‐J‐256: Predicting Metastasis‐Free Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemo‐Radiotherapy by Data‐Mining of CT Texture Features of Primary Lesions

The Prognostic Value of Positron Emission Tomography/computed Tomography-Based Parameters in Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Chemoradiation Therapy

Quantitative Measurement of Contrast Enhancement of Esophageal Squamous Cell Carcinoma on Clinical MDCT.

Chemoradiotherapy-Induced CD4+ and CD8+ T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma.

Tumor Heterogeneity in Oral and Oropharyngeal Squamous Cell Carcinoma Assessed by Texture Analysis of CT and Conventional MRI: a Potential Marker of Overall Survival

Prognostic Role of Computed Tomography Textural Features in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy

Survival Analysis for Patients with T4bsquamous Cell Carcinoma of Thoracic Esophagus Receiving Concurrent Chemoradiotherapy

Study on the Changes of CT Texture Parameters Before and after HCC Treatment in the Efficacy Evaluation and Survival Predication of Patients with HCC.

Profiling Analysis Reveals Potential Prognostic Biomarkers for Esophageal Cancer Patients Treated with Radiation Therapy

Establishing a Survival Prediction Model for Esophageal Squamous Cell Carcinoma Based on CT and Histopathological Images.

Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma

A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy.

Combined Modalities of Magnetic Resonance Imaging, Endoscopy, and Computed Tomography in Evaluation of Tumor Response to Definitive Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

Investigation of Using Diffusion-Weighted Magnetic Resonance Imaging (DWI) Combined with CT and Esophagogram to Evaluate the Therapeutic Effect of Esophageal Squamous Cell Carcinoma (ESCC) Treated with Chemoradiotherapy

Making Esophageal Squamous Cell Carcinoma Survival Prediction from Histopathological Images and CT Images.

Survival Differences Between Chemotherapy and Chemoradiotherapy in Metastatic Esophageal Cancer: a Propensity Score-Matched Study Based on the SEER Database